Teva - Statistics & Facts
Key insights
- Global generic Rx drug sales forecast for 2026
- 99 bn USD
Detailed statistics
Worldwide generic prescription drug sales 2012-2026
- Rx drug revenue at risk from patent expiration in 2028
- 99 bn USD
Detailed statistics
Patent expiration risks for total worldwide prescription drug revenue 2023-2028
- Top global generic drug manufacturer by 2022 sales
- Teva
Detailed statistics
Revenues of leading global generics manufacturers 2022
Editor’s Picks Current statistics on this topic
Current statistics on this topic
Related topics
Recommended statistics
Global positioning
5
- Premium Statistic Total worldwide prescription drug revenue - projection 2020-2028
- Basic Statistic Worldwide generic prescription drug sales 2012-2026
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
- Premium Statistic Revenues of leading global generics manufacturers 2022
- Premium Statistic AMR score among generic medicine manufacturers in 2021
Global positioning
-
Premium Statistic
Total worldwide prescription drug revenue - projection 2020-2028
Total worldwide prescription drug revenue - projection 2020-2028
Projected worldwide total prescription drug revenue from 2020 to 2028 (in billion U.S. dollars)
-
Basic Statistic
Worldwide generic prescription drug sales 2012-2026
Worldwide generic prescription drug sales 2012-2026
Worldwide generic prescription drug sales from 2012 to 2026 (in billion U.S. dollars)
-
Premium Statistic
Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
Leading 50 global pharmaceutical companies by prescription sales and R&D spending in 2022 (in billion U.S. dollars)
-
Premium Statistic
Revenues of leading global generics manufacturers 2022
Revenues of leading global generics manufacturers 2022
Leading generics manufacturers worldwide based on revenue in 2022 (in billion U.S. dollars)
-
Premium Statistic
AMR score among generic medicine manufacturers in 2021
AMR score among generic medicine manufacturers in 2021
Antimicrobial resistance score among generic medicine manufacturers in 2021
Key figures
5
- Premium Statistic Teva Pharmaceutical Industries' revenue 2006-2023
- Basic Statistic Teva Pharmaceutical Industries' net income 2006-2023
- Basic Statistic Teva Pharmaceutical Industries' total assets 2011-2023
- Basic Statistic Teva Pharmaceutical Industries: earnings per share 2006-2023
- Premium Statistic Teva Pharmaceutical's number of employees 2018-2023 by region
Key figures
-
Premium Statistic
Teva Pharmaceutical Industries' revenue 2006-2023
Teva Pharmaceutical Industries' revenue 2006-2023
Revenue of Teva Pharmaceutical Industries from 2006 to 2023 (in million U.S. dollars)
-
Basic Statistic
Teva Pharmaceutical Industries' net income 2006-2023
Teva Pharmaceutical Industries' net income 2006-2023
Net income of Teva Pharmaceutical Industries from 2006 to 2023 (in million U.S. dollars)
-
Basic Statistic
Teva Pharmaceutical Industries' total assets 2011-2023
Teva Pharmaceutical Industries' total assets 2011-2023
Total assets of Teva Pharmaceutical Industries from 2011 to 2023 (in million U.S. dollars)
-
Basic Statistic
Teva Pharmaceutical Industries: earnings per share 2006-2023
Teva Pharmaceutical Industries: earnings per share 2006-2023
Earnings per share of Teva Pharmaceutical Industries from 2006 to 2023 (in U.S. dollars)
-
Premium Statistic
Teva Pharmaceutical's number of employees 2018-2023 by region
Teva Pharmaceutical's number of employees 2018-2023 by region
Number of employees at Teva Pharmaceutical Industries from 2018 to 2023, by region
Competitors
-
Premium Statistic
Novartis revenue 2014-2023 by segment
Novartis revenue 2014-2023 by segment
Novartis AG's revenue from 2014 to 2023, by segment (in billion U.S. dollars)
-
Premium Statistic
Viatris' net sales in 2023, by business segments
Viatris' net sales in 2023, by business segments
Viatris' net sales in 2023, by business segments (in million U.S. dollars)
-
Premium Statistic
Sun Pharma's sales FY 2015-2022
Sun Pharma's sales FY 2015-2022
Sun Pharmaceutical Industries Limited sales value from financial year 2015 to 2022 (in billion Indian rupees)
-
Premium Statistic
Aurobindo Pharma's revenue FY 2013-2023
Aurobindo Pharma's revenue FY 2013-2023
Revenue of Aurobindo Pharma Limited from financial year 2013 to 2023 (in billion Indian rupees)
Costs and expenses
-
Basic Statistic
Teva: expenditure on research and development 2006-2023
Teva: expenditure on research and development 2006-2023
Expenditure on research and development by Teva Pharmaceutical Industries from 2006 to 2023 (in million U.S. dollars)
-
Basic Statistic
Teva Pharmaceutical Industries' selling and marketing expenses 2011-2023
Teva Pharmaceutical Industries' selling and marketing expenses 2011-2023
Selling and marketing expenses of Teva Pharmaceutical Industries from 2011 to 2023 (in million U.S. dollars)
-
Basic Statistic
Teva Pharmaceutical Industries' legal settlements 2014-2023
Teva Pharmaceutical Industries' legal settlements 2014-2023
Legal settlements of Teva Pharmaceutical Industries from 2014 to 2023 (in million U.S. dollars)
Regions and segments
-
Premium Statistic
Teva Pharmaceutical Industries's revenue 2018-2023 by region
Teva Pharmaceutical Industries's revenue 2018-2023 by region
Revenue of Teva Pharmaceutical Industries from 2018 to 2023, by region (in million U.S. dollars)
-
Premium Statistic
Teva Pharmaceutical Industries' generic revenues by region 2016-2023
Teva Pharmaceutical Industries' generic revenues by region 2016-2023
Generic revenues of Teva Pharmaceutical Industries from 2016 to 2023, by region (in million U.S. dollars)
-
Premium Statistic
Teva Pharmaceutical Industries' specialty medicines revenues breakdown 2018-2023
Teva Pharmaceutical Industries' specialty medicines revenues breakdown 2018-2023
Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2018 to 2023 (in million U.S. dollars)
Further reportsGet the best reports to understand your industry
Get the best reports to understand your industry
Contact
Get in touch with us. We are happy to help.
Meredith Alda
Sales Manager– Contact (United States)
Mon - Fri, 9am - 6pm (EST)
Yolanda Mega
Operations Manager– Contact (Asia)
Mon - Fri, 9am - 5pm (SGT)
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)
Mon - Fri, 10:00am - 6:00pm (JST)
Lodovica Biagi
Director of Operations– Contact (Europe)
Mon - Fri, 9:30am - 5pm (GMT)
Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Mon - Fri, 9am - 6pm (EST)